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Executive summary 
The causes of the current global threat of antimicrobial resistance (AMR) are complex but the overuse 
of antibiotics in both the human and livestock health sectors is widely recognised as a contributing 
factor. Data collection on antibiotic use is central to the global surveillance plans of the World Health 
Organisation (WHO) and the World Organisation for Animal Health (OIE). Typically, antibiotic 
surveillance aims to collate national sales figures expressed per human or livestock population as a 
starting point, although this is currently highly incomplete, especially in most low-income and middle-
income countries (LMICs). However, there is even less data available on antibiotic use at the granular 
level i.e. on provision by individual provider type and use by individual patients or livestock keepers. 
Interventions aimed at reducing risk are often aimed at this level; maximising effectiveness will require  
addressing this gap in rigorous and representative granular data.  
This rapid scoping review aimed to identify the range of methods available for collection of antibiotic 
use data at the granular level in LMICs for both human and livestock health. It was conducted as a 
background document for a roundtable discussion on methods and metrics for studying human and 
livestock antibiotic use at the granular level in London in November 2017. We did not aim to conduct 
a systematic review of all publications involving measurement of antibiotic use, but rather to provide 
an overview of the types of guidance and studies currently available, and the characteristics of their 
data collection procedures. Although the focus was specifically on antibiotics, we also included 
publications with a more general focus on all medicines, all antimicrobials or all “chemicals” (in 
aquaculture), if they included antibiotics. Whilst the focus of the review was on methods producing 
actual volume usage data at the granular level, publications containing such metrics were quite 
limited. We therefore also included those with other metrics relating to antibiotic use (e.g. proportion 
of patients receiving an antibiotic), where the methods could potentially be adapted to measure actual 
volumes. The publications were organised into two groups: i) standard survey tool guidelines and 
protocols and ii) published studies with examples of methods used in the field. 
Standard survey tools and protocols within human health, published by the WHO through various 
channels and collaborations, include the International Network for Rational Use of Drugs (INRUD), 
Health Action International’s Affordability and Availability of Medicines, Country Pharmaceutical 
Situation Assessments, Health Care Delivery Situational Analysis and the Use of medicines by 
Consumers. Others are published within the Service Provision Assessment in Demographic and Health 
Surveys and the Hospital Antimicrobial Use investigation by Strengthening Pharmaceutical Systems. 
The majority of these tools produce indicators to assess rational use of medicines, availability and 
affordability of medicines, or provide a rapid assessment of problem areas in prescribing behaviours 
and usage either within hospitals, licenced retailers or community members, but are not designed to 
generate outputs associated with usage of antibiotics by volume. Within the livestock sector, the 
standardised tools were limited to the OIE’s global database at the national level, with none found at 
the granular level. No standardised tools were identified from a One Health perspective.  
Research papers were reviewed to identify the range of methods and metrics used, until saturation in 
methods was reached. A sample of 48 human health and 30 livestock health research papers based in 
LMICs were selected for a more detailed review, representing a range of methods and metrics for 
quantifying antibiotic use. Papers were reviewed to extract data collection points, data collection 
methods, metrics, sampling strategies, geographical scope and disease focus (human) or species focus 
(livestock).  
Data collection points within the human health papers included public hospitals and primary health 
care facilities (e.g. dispensaries, small private hospitals and private GPs), drug retailers (e.g. 
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pharmacies and drug shops) and households. Within human health papers, patient exit interviews (on 
exiting a healthcare facility) and inpatient record analysis were the most common methods used in 
hospitals and primary health care facilities (referred to as health facilities hereafter). Exit interviews 
with clients were again the most common method in drug retailers whilst household questionnaires 
were most common at the population level. Data collection points within the livestock papers were 
limited to livestock keepers (who predominated), drug retailers, pharmaceutical reps, veterinarians 
and feed retailers. Questionnaires were the most commonly used method for livestock health across 
all data sources (livestock keepers, drug retailers, vets and feed retailers), whilst other methods used 
for livestock keepers were treatment logs and used packaging.  
Most human health papers collecting data from health facilities and from drug retailers used an 
existing list of facilities for a sampling frame and had a relatively small sample size of either <100 
facilities or <1000 patients. Household surveys typically did not state their sampling frame source and 
included sample sizes of mostly >100 if based on households or <1000 if based on individuals. Within 
livestock papers, the majority did not state their sampling frames and most had sample sizes of <500 
facilities.  
The vast majority of human health papers produced outputs relating to INRUD methods, which focus 
on % of patients prescribed or receiving antibiotics, types of antibiotics, % antibiotics supplied with or 
without prescription, or the % of antibiotics prescribed per disease or symptom. Only 12 of the 48 
papers produced Defined Daily Dose (DDD)1 related metrics, with most of these collected from health 
care facilities.  Similarly only four of the 30 livestock papers used DDD associated metrics, with most 
producing metrics on % of respondents using antibiotics, which antibiotic type and their reasons for 
using. 
Of the human health papers, collecting data from either health facilities or drug retailers, most were 
from South Asia and Sub-Saharan Africa and were predominantly from urban settings. Four papers 
were located in more than one country and more than one region. Livestock papers were 
predominantly from work in Sub-Saharan Africa and East Asia and the Pacific.  
Human health papers mostly covered any or all conditions while a minority had a specific disease or 
symptom focus. Of the latter, most focused on antibiotic use in diarrhoea, respiratory symptoms or 
acute fever. Livestock papers tended not to focus on a specific disease or symptom but were more 
species specific. Poultry and aquatic species predominated.  
Key current developments in measurement of antibiotic volumes include work by WHO to develop a 
protocol for measuring use in hospitals in LMICs on the basis of prescribed daily doses of inpatients. A 
current research project, Antibiotic Access and Use (ABACUS) is collecting data in Health and 
Demographic Surveillance System sites in six LMIC via patient exit interviews from providers including 
hospitals, smaller healthcare facilities and drug retailers (including informal). They aim to produce 
metrics of “antibiotic exposure” (i.e. % of customers leaving with antibiotics) and the “antibiotic 
burden” (i.e. the DDD supplied per 100 antibiotic encounters per antibiotic type).  
In summary, while the review indicated that considerable experience and expertise exists on antibiotic 
use data collection, and a number of valuable resources are available, a number of gaps were 
identified. Geographical coverage of existing studies is very patchy both across and within countries, 
with only a few hospital studies having nationwide representation, and rural areas generally less likely 
to be studied. Most human health and livestock papers had relatively small sample sizes and, apart 
from studies on registered health facilities and pharmacies, it was often unclear whether the sample 
                                                          
1 DDD is the assumed average maintenance dose for a drug for a 70 kg adult for its main indication 
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was drawn from a complete sampling frame. Only a minority of human health and livestock papers 
produced Defined Daily Dose (DDD)2 related metrics, and only one study (livestock) was identified 
which compared different data collection methods for measuring antibiotic volumes. Papers tended 
to focus on one or at most two providers or livestock keeper types. Most standard protocols and 
papers for human health focused on registered health care facilities and drug outlets, with relatively 
few including informal providers, and none including itinerant drug sellers and market stalls. Coverage 
of livestock keeper types was also patchy, with many papers giving insufficient information about 
livestock keeper type. Livestock papers were typically species specific, with poultry and aquatic species 
predominating, and no studies including all livestock. Only one paper attempted to cover both human 
and livestock antibiotic use. Finally, no resources or papers which we identified adopted a total market 
approach i.e. none included all providers of antibiotics within a given geographical area, though this 
is the aim of ABACUS. Using a total market approach is demanding in terms of logistics and creation 
of comparable tools across providers, but would be very valuable to assess the relatively market 
shares of different provider types.  
 
  
                                                          
2 DDD is the assumed average maintenance dose for a drug for a 70 kg adult for its main indication 
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Introduction 
Antibiotics are one of the foundations of both human and veterinary medicine and surgery today, with 
many of the same antibiotics used across several species. The selective pressure on bacterial 
populations exerted through the use of antibiotics has been well documented as a driver of 
antimicrobial resistance (AMR). Usage data should therefore form an essential part of the surveillance 
system, and a key input in the development of strategies to contain AMR. Given that the terrestrial 
and aquatic livestock, which form our food system, are often exposed to antibiotics during their 
lifetime, a One Health approach to antibiotic usage surveillance is recommended. 
Interventions to address resistance should be built on evidence from rigorous and representative data 
on the provision and use of antibiotics within different settings and across different sectors. Whilst 
such data are becoming increasingly available in high-income countries (HICs), they are far more 
limited in low and middle income countries (LMICs). Within the human health sector, the pluralistic 
nature of health systems makes data collection particularly challenging, with antibiotics accessed 
through a wide mix of public, not for-profit and both formal and informal for-profit organisations. 
Private for-profit providers are particularly diverse, encompassing international-standard corporate 
hospitals, small scale hospitals and clinics, pharmacies, drug shops, and in some settings general 
retailers and itinerant vendors, with smaller less qualified providers often major medicine suppliers, 
and on-line provision growing rapidly. Antibiotic provision in LMICs within the livestock sector is 
equally diverse, but with a greater proportion of suppliers in the private for-profit sector. Antibiotics 
in livestock are used not only for therapeutic purposes but also for growth promotion, prophylactic 
and metaphylactic use. Various supply chains exist depending on the scale of livestock keeping 
establishments, and the quantities used can be hard to interpret as they are often administered via 
feed and water. Furthermore, the human and livestock sectors may not be entirely distinct at the local 
level, with antibiotics being sold through the human health supply chain for use in livestock. 
Attempts to further the agenda around collection of antibiotic use data should ideally take place 
within the frameworks developed at a multinational level for antibiotic consumption in both humans 
and livestock. Collection of data on antibiotic use is central to the World Health Organisation’s (WHO) 
Global Action Plan (GAP) on AMR and is an expected core component of member states’ National 
Action Plans. The WHO’s Methodology for a global surveillance program of antimicrobial consumption 
aims to provide a common methodology for the measure of antimicrobial consumption to allow 
monitoring at a national, regional and global level. The manual includes suggestions on setting up a 
national surveillance plan, with a focus on “consumption” data (which it defines as estimates from 
aggregated data sources). Measuring consumption data is seen as a significant starting point for many 
countries with limited resources. Whilst it recommends Anatomical Therapeutic Chemical 
(ATC)/Defined daily Dose (DDD) metrics (i.e. DDD/population unit/time), the degree of granularity of 
the “usage” data (which it defines as patient level data) is left open to the individual countries to 
choose, based on availability of the data and their resources. The methodology does not attempt to 
provide advice on detailed sampling and protocols for assessing use at the granular level (i.e. by 
provider or patient type) for individual countries.  
The World Organisation for Animal Health (OIE) has been tasked, with the support of the Food and 
Animal Organisation (FAO), to contribute to the Global Action Plan and is building a global database 
on antimicrobial agents intended for use in animals. This aims to monitor the type and use of 
antimicrobial products, usage trends over time, trace global circulation and usage patterns and 
evaluate the quality and authenticity of antimicrobials in use. This data collection process is in the 
early phases having been launched in the latter half of 2015. It is currently at the macro or 
“consumption” level, relying on member countries to report total national sales data in kilograms of 
9 
 
antimicrobial agent for antimicrobials “destined for use in animals” and those agents on the OIE’s list 
of “antimicrobial agents of veterinary importance”. The reporting of disaggregated data is dependent 
on its availability within each member country. Three reporting options exist: Option 1 requires 
distinction of antimicrobial agents by use (therapeutic or growth promotion); Option 2 by type of use 
and animal groups (all food producing, terrestrial-food producing, aquatic-food producing and 
companion animals) and species; and Option 3 by type of use, animal groups and species and routes 
of administration. The OIE reporting template lists details of possible data sources (including 
manufacturers, wholesalers, retailers, import, marketing authorities, veterinarians, pharmacists and 
agricultural stores and feed manufacturers and farmers) for use as a reference. However, as with the 
WHO methodology, there is a lack of detail on methods for data collection for individual countries at 
the granular level.  
Whilst high-level macro or consumption data is a useful starting point for documenting comparisons 
of regions or countries and for monitoring trends over time, the design of interventions is often 
focussed at the lower level i.e. prescriber, dispenser and end user. To anticipate where to maximise 
intervention leverage, disaggregated, granular data are required. We need to know how the 
antibiotics consumed by humans are distributed across provider types (hospitals, pharmacies, other 
retailers etc.), across different disease syndromes, and across different socio-economic groups, and 
how this varies by antibiotic class. In the agricultural domain, we need to know how antibiotic use is 
distributed across supplier type, farm type, animal species and purpose (growth promotion, 
treatment, prophylaxis), and again by antibiotic class.  For these data to be useful it is essential to use 
rigorous and representative methods for documenting which antibiotics are used, where and when 
and in what quantities within human and livestock health, taking into account the complexities of 
these markets outlined above.  
A number of standard methods have been developed by WHO to investigate rational use of medicines 
in hospitals and communities, and numerous individual research studies have been conducted 
collecting granular data on antibiotic use within the human and livestock health sectors. The aim of 
this review is to collate these methodologies from across both sectors to help identify best practices, 
and to provide a foundation for developing or fine-tuning methods and metrics, with a view to 
designing future data collection systems and studies that can provide robust data at the granular level 
to inform future policy and interventions. 
Review methods 
We conducted a rapid scoping review of published literature to identify the range of methods available 
and in use for collection of antibiotic use data at the granular level in LMICs. We did not aim to conduct 
a systematic review of all publications involving measurement of antibiotic use, but rather to provide 
an overview of the types of guidance and studies currently available, and the characteristics of their 
data collection procedures. The review included both human and livestock health (including both 
terrestrial and aquatic livestock). Although the focus was specifically on methods to measure use of 
antibiotics, we also included publications with a more general focus on all medicines, all antimicrobials 
or all “chemicals” (in aquaculture), if they included antibiotics. Data collection points within human 
studies included all those interacting directly with patients including hospitals, health centres and drug 
retailers, together with households. Within livestock, studies collecting data from livestock keepers, 
drug retailers, veterinarians, pharmaceutical reps and feed retailers were included. Literature relating 
to high-level “consumption” data was excluded. Whilst the focus of the review was on methods 
producing actual volume usage data at the granular level, publications containing such metrics were 
quite limited. We therefore also included those with other metrics relating to antibiotic use (e.g. 
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proportion of patients receiving an antibiotic), where the methods could potentially be adapted to 
measure actual volumes. Studies using simulated patients or hypothetical cases were excluded as 
these do not provide actual antibiotic use data (though they can of course be extremely useful for 
other purposes).   
Literature searches were limited to publications in the English language and were conducted through 
PubMed and Science Direct to identify primary papers. Further snowball searching from the reference 
lists of individual primary papers was conducted. Grey literature and websites from the World Bank, 
WHO, OIE, Health Action International (HAI), Demographic and Health Surveys’ (DHS) Service Provision 
Assessments (SPA), Strengthening Pharmaceutical Systems (SPS) Program, Global Antibiotic 
Resistance Partnership (GARP) and ReACT were also searched.  
Professional networks and selected publications from the literature review were used to create an 
initial list of key informants to interview. These individuals were asked to identify additional resources 
and publications, to share knowledge of current or recent developments, and to recommend further 
key informants to interview, as well as workshop invitees. Where applicable, they also commented on 
their experience using different methods in their fieldwork. Interviews were conducted in English, 
primarily via Skype and a full alphabetical list of interviewees is attached as Annex 1. 
The publications were organised into two groups: i) standard survey tool guidelines and protocols, and 
ii) published studies with examples of methods used in the field. Selected information from all 
included publications was abstracted using standard reporting matrices for these two groups.  
Review results 
The review results are presented in three sections. Firstly, the standard survey tools and protocols 
from the human and livestock health sectors are described. The second section covers research 
publications, where across a spectrum of data collection sources, we provide details of publications 
by their methods, sampling strategies, outputs and geographic location and scope, and disease focus 
and species focus (livestock). The final section highlights some current developments in standard 
methodologies and research projects. 
Standard survey tools and protocols 
Published manuals of standard survey tools and protocols associated with usage data collection at the 
level of human healthcare facilities and patients/consumers were assessed for relevance to antibiotic 
use at the granular level in LMICs. The results are summarised below and presented in Table 1.3 
These tools and indicators are mostly aimed at healthcare facilities and mainly derived from the drug 
use indicators set out by the WHO’s International Network for Rational use of Drugs (INRUD). Some 
focus on assessing drug use behaviour in all health facilities [How to investigate drug use in health 
facilities (WHO, 1993) and the Drugs and Therapeutics Committees – A Practical Guide WHO 2004], 
whilst others focus specifically on antimicrobial use in hospitals [How to Investigate Antimicrobial Use 
in Hospitals: Selected Indicators. Strengthening Pharmaceutical Systems (USAID/SPS) 2012]. Indicators 
relevant to antibiotic use include i) the average number of drugs (including antibiotics) per encounter, 
ii) the percentage of encounters with a prescribed antibiotic, iii) percentage of drug costs spent on 
antibiotics, iv) percentage of prescriptions in accordance with treatment guidelines, v) percentage of 
hospitalisations with antimicrobials prescribed, vi) average number of antimicrobials (some cases 
specifying antibiotics) per inpatient day, vii) average duration of treatment, viii) average cost per 
                                                          
3 Many of these tools and others related to high income county settings are collated in the ReACT Toolbox 
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hospitalisation, and  ix) percentage of patients receiving antimicrobials for caesarean section or for 
pneumonia respectively.4  
At a country level, there are assessment tools for the analysis of the pharmaceutical situation [WHO 
Operational package for assessing, monitoring and evaluating country pharmaceutical situations]  and 
the management of medicines in health care [The workbook tool for Country Situational Analyses of 
Medicines Management in Health Care Delivery, presented by the WHO South East Asia Regional 
Office]. Their outputs include percentage of patients prescribed antibiotics (including those relating to 
a specific symptom e.g. upper respiratory tract), percentage of prescription medicines bought without 
a prescription, and percentage of upper respiratory tract infection patients prescribed antibiotics. Once 
again, these are not aimed at quantifying use but are rather a rapid assessment to identify problem 
areas and prioritise solutions related to prescribing behaviours and rational use. 
Other tools capture data on the affordability and/ or availability of medicines, but do not capture data 
on use / volumes. The WHO/ Health Action International (HAI) produce outcomes including, 
availability by dosage form and strength and price of drugs available at a range of provider types, while 
health facilities may be subject to a DHS Service Provision Assessment, which includes an inventory 
survey of antibiotics which are currently in stock, but does not quantify them.  
At the consumer level, the WHO’s How to investigate the use of medicines by consumers aims to 
understand drug use practices and identify usage problems at the patient level. It includes a variety of 
methods which can be used at the consumer level, but does not specifically generate outputs 
associated with measuring usage by volume.  
Within the Veterinary and Livestock sector, standardised tools were limited to the OIE’s global system 
for measuring antibiotic or antimicrobial use at the higher, national level, with none found at the 
granular level, nor were any identified from a One Health perspective.  
 
 
  
                                                          
4 A systematic review of studies using these indicators was published in 2009, covering published studies from 
96 countries. See Medicines use in primary care in developing and transitional countries: Fact Book 
summarizing results from studies reported between 1990 and 2006. 
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Table 1: Standard survey tools and protocols for human antibiotic use, applicable at granular level 
Resource 
Data Collection 
point 
Data collection 
methods relevant 
for granular AB 
use 
Sampling frame 
Suggested sample 
size 
Scope of drugs covered 
Output metrics 
relevant to AB 
use 
Number of 
countries 
implemented 
How to investigate drug use 
in health facilities (WHO, 
1993) 
 
Variety of public 
or private health 
facilities (health 
centres, 
dispensaries, 
hospital 
outpatients) 
- Out-patient 
records 
(retrospective over 
12 m) 
- Out-patient 
encounters 
observation 
(prospective)  
- Drug Inventory 
survey  
Specified health 
facilities 
depending on 
study objectives 
(either from 
official lists or 
from data 
gathered/ census) 
600 patient 
encounters (either 
from records or 
observation) i.e. 30 
patients in 20 
facilities or 100 
patients per facility 
or prescriber or 
condition for inter-
facility or prescriber 
comparisons 
Specified range of 
available drugs, Essential 
Medicines List (EML) or 
specific lists dependent on 
study objectives  
- average no. of 
drugs per 
encounter  
- % of encounters 
with a prescribed 
antibiotic 
- % of drug costs 
spent on 
antibiotics 
 
n/s 
How to investigate the use 
of medicines by consumers 
(WHO, 2004) 
- Households 
- Community drug 
outlets (e.g. 
pharmacies and 
drug stores) 
- Health facilities, 
public and private 
(health centres, 
hospitals) 
- Documents (sales, 
prescriptions) 
- Questionnaires 
(from all data 
collection points) 
-Simulated clients, 
inventories of 
drugs stocked 
Specified health 
facilities 
depending on 
study objectives 
(either from 
official lists or 
from data 
gathered/ census) 
If a sampling frame 
exists or can be 
created, probability 
sampling should be 
used. Sample size will 
depend on the 
variation in the data. 
Aim for at least 30 
individuals in each 
group of interest (or 
data collection 
point). Consult 
statistician for more 
complex quantitative 
study designs 
Specified range of 
available drugs, EML or 
specific dependent on 
study objectives 
Outcomes are 
dependent on 
study objectives 
but aim to 
understand drug 
use practices and 
are not 
specifically 
volume related 
n/s 
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Resource 
Data Collection 
point 
Data collection 
methods relevant 
for granular AB 
use 
Sampling frame 
Suggested sample 
size 
Scope of drugs covered 
Output metrics 
relevant to AB 
use 
Number of 
countries 
implemented 
How to Investigate 
Antimicrobial Use in 
Hospitals: Selected 
Indicators. Strengthening 
Pharmaceutical Systems 
(SPS) 2012 
Hospitals (private 
and public) 
- Hospital 
pharmacy 
inventory of drug 
stocks 
- In-patient records 
(retrospective or 
prospective) 
Listed hospitals or 
purposively 
selected 
100 prescribing 
encounters per 
facility 
Specified range of 
available antimicrobials 
and EML, but generally 
exclude anti-tuberculosis 
drugs and anti-retroviral 
drugs for HIV 
-  % of 
hospitalisations 
with 
antimicrobials 
prescribed  
- average no. of 
antimicrobials 
per inpatient day  
- average 
duration of 
treatment  
- % of patients 
receiving 
antimicrobials for 
C-section or 
pneumonia 
n/s 
WHO Operational package 
for assessing, monitoring 
and evaluating country 
pharmaceutical situations 
(WHO, 2007) 
- Public health 
facilities 
- Public and 
private 
pharmacies 
- Public drug 
supply 
warehouses 
- Patient/ 
prescription 
records 
(retrospective over 
12 m) 
- Patient exit 
interviews (30 
patients) 
Listed facilities or 
census for 
smaller/ private 
outlets 
30 patients at 30 
health facilities of 
each type and 5 
warehouses 
Specified range of 
available drugs, EML  
- % of patients 
prescribed 
antibiotics  
- % of 
prescription 
medicines bought 
without a 
prescription 
>40 
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Resource 
Data Collection 
point 
Data collection 
methods relevant 
for granular AB 
use 
Sampling frame 
Suggested sample 
size 
Scope of drugs covered 
Output metrics 
relevant to AB 
use 
Number of 
countries 
implemented 
The WHO/ Health Action 
International (HAI) 2008 
- Public sector 
(hospitals, clinics, 
health centres) 
- Private sector 
(licensed 
pharmacies, drug 
stores) 
- Other (eg 
unlicensed drug 
outlets and 
vendors, private 
hospitals and GPs, 
NGO and religious 
facilities) 
Questionnaire with 
inventory check for 
price 
Dependent on 
sector:  
- Public and 
private (licenced) 
listed facilities 
- Other listed or 
created by census 
 
Six regions each with 
5 public (1 hospital + 
4 outlets) and 5 
private outlets a) and 
5 “other” outlets  
Specified range of up to 50 
drugs made up of global 
core medicines list, 
regional core list and 
supplementary list based 
on individual country 
significance 
- None (only 
collects data on 
availability and 
price)  
36 
The workbook tool for 
Country Situational Analysis 
of Medicines Management 
in Health Care Delivery, 
presented by the WHO 
South East Asia Regional 
Office (WHO, 2013) 
 
Selection of public 
and private to 
represent the 
facility types 
present (university 
hospitals, district 
level public 
hospitals, primary 
health care 
centres, 
dispensaries, 
private and non-
hospital public 
pharmacies)  
- Patient records  
- Prescription 
records  
- Exit interviews  
- Inventory of drugs 
stocked 
Listed and 
licensed facilities 
2 regions each with 
1-2 facilities of each 
type to give 16-24 
facilities in total; 
30-60 patient or 
prescribing 
encounters at each 
facility 
Specified range of drugs 
from EML or others 
depending on country 
- % of patients 
prescribed 
antibiotics  
- % of upper 
respiratory tract 
infection patients 
prescribed 
antibiotics 
11 (in South 
East Asia 
Region) 
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Resource 
Data Collection 
point 
Data collection 
methods relevant 
for granular AB 
use 
Sampling frame 
Suggested sample 
size 
Scope of drugs covered 
Output metrics 
relevant to AB 
use 
Number of 
countries 
implemented 
The Demographic and 
Health Surveys’ Service 
Provision Assessment 
survey and Inventory survey 
Formal public and 
private facilities 
(excludes 
pharmacies and 
individual doctors) 
Questionnaire with 
inventory check for 
availability of 
antibiotics. 
Backed up with 
observations 
(patient 
encounters) and 
patient exit 
interviews 
Listed health 
facilities by sector 
(public and 
private) and 
facility type 
400-700 facilities List of 22 antibiotics 
including oral, injectable 
and ointments 
- None (only data 
on antibiotic 
availability i.e. at 
least one of 
specified 
antibiotic is 
present) 
15  
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Research publications 
Research publications reporting granular data on antibiotic use are numerous, therefore we 
reviewed a selection of papers, to identify examples of methods and metrics used for a range of data 
collection points, until saturation of methods was reached. A sample of 48 papers from the human 
health sector (Annex 2) and 30 papers from the livestock health sector (Annex 3) were analysed. 
Only one paper was identified covering both human and livestock antibiotic use (Roess et al., 2015). 
It supplemented an existing neonate and maternal health project in Bangladesh and is included in 
the livestock data analysis below. 
Information was extracted from each paper on key elements of the study design and methods, 
including data collection points, geographical scope, disease focus (human) or species focus 
(livestock), sampling approach, and outcomes or metrics used. The results are presented in Tables 2-
7 and Figures 1-6 below. 
1. Data collection methods 
We categorised human health papers by type of data collection point, namely hospitals and primary 
health care facilities, drug retailers (both with a number of sub-categories), and also households (Table 
2a). Several papers accessed data from more than one data collection point. The majority of the 
papers (21/48) involved data collection from public hospitals and primary health care facilities such as 
dispensaries, small private hospitals and private GPs (hereafter we refer to all these facility types as 
“health facilities”). Of these papers, around three quarters used public hospitals as their data 
collection point, with an almost even split of papers across the remaining sub-categories. Just under 
a third of papers (15/48) collected data from drug retailers, which included licensed and unlicensed 
pharmacies and drug shops, with pharmacies being the predominant sub-category, whilst 19 papers 
obtained data from households. We did not identify any studies of itinerant vendors or market stalls 
though these are significant medicine providers in some contexts. 
The data collection methods used in these human health studies were categorised into the following 
eight types (Table 2a shows methods used across the full spectrum of data collection points whilst 
Figure 1 shows them across three main categories): 
1. Exit interviews: patients exiting health care facilities or clients exiting retailers are selected to 
take part in an interview regarding their antibiotic purchase 
2. Encounter observation: the encounter of the patient with the prescriber, dispenser or 
supplier of antibiotics is observed by the researcher and details recorded. 
3. Inpatient records: these draw on routine provider records, and can be retrospective studies, 
looking at patient usage over a period of time, or prospective, involving a number of current 
patients over usually a shorter period. 
4. Prescribing or dispensing records: similar to patient records but based on outpatient records 
and outlet dispensing records 
5. Bulk purchase and/or sales records: from individual outlets over a period of time 
6. Provider questionnaire: structured or semi-structured, usually conducted via face-to-face 
interviews with drug provider 
7. Household questionnaire: as above but at the household level. 
8. Inventory of drugs stocked: checking antibiotics stocks on shelves of outlets or those kept in 
patients’ households 
9. A combination of the above: either a combination of different methods or a blend e.g. patient 
exit interviews, which included observation of medications dispensed or details of written 
prescription received 
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Typically, patient exit interviews were conducted by trained individuals including pharmacists or 
medical or pharmacy students, often working in pairs, one to identify the patients receiving antibiotics 
and the other to conduct the interview (Kotwani et al., 2009). Patients may be interviewed within the 
facilities or on the street outside (Kotwani and Holloway, 2011).  
Encounter observations were conducted by investigators who observed and recorded all information 
on a form; details relating to the individual patient and the drugs which were prescribed or dispensed, 
including compliance with prescribing the actual drug on the prescription. Typically, investigators were 
masters students or newly qualified pharmacists. The facility under observation was often told that 
the study was interested in all drugs, not antibiotics specifically to reduce potential bias (Nga et al., 
2014).  
Retrospective data were commonly extracted manually from inpatient records or from outpatient 
registers at health centre facilities (Guyon et al., 1994). Bulk purchase data were extracted from 
purchase receipts using a detailed form with names and strengths of drugs of interest. Data were 
usually collected in pairs using data collectors with pharmacy backgrounds, who would visit every 15 
days to collect and analyse receipts (Kotwani et al., 2009). 
Questionnaires conducted at the household level usually requested recall of antibiotic use over the 
past week or up to a month. They were typically a combination of structured and semi-structured 
questionnaires (Larsson et al., 2000). Photo-cards may be used to help identify drugs by name and 
determine whether they were indeed antibiotics. In Kerala State, South India patients were found to 
commonly retain their prescription slips at home together with packaging and wrappers, which 
assisted researchers in confirming medication received (Saradamma et al., 2000). 
While provider questionnaires were commonly used to obtain antibiotic use data from drug retailers 
and household questionnaires from individuals, this method was not used at health facilities. Within 
the 21 health facility papers, an equal number (nine) used patient exit interviews and inpatient 
records, whilst six used prescription or dispensing records. 
Of the 15 papers which focused on drug retailers, nine used exit interviews followed by six using 
provider questionnaires, while four used encounter observations and four dispensing records. Out of 
the 19 papers using household data, all used questionnaires, whilst six included an inventory check of 
drugs kept in the house. One household study (Rogawski et al., 2017) additionally randomly selected 
medical care reports from health care workers to validate questionnaire results. 
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Table 2a: Data collection methods used by type of data collection point in human health sector 
Human health papers n=48  Method 
Data collection 
points 
No. of 
papers 
Exit 
interviews 
Encounter 
observation 
Inpatient 
records 
Prescription/ 
dispensing 
records 
Bulk purchase/ 
sales records 
Questionnaire 
Provider/ 
Household 
Inventory of 
drugs 
stocked/ kept 
All data collection 
points  
48 14 7 9 9 3 21 6 
Hospitals and 
primary health 
care facilities 
21 9 3 9 6 2 0 0 
Public hospital 20 7 2 8 7 1   
Primary Health 
care facilities  
5 5 1 1 1    
Private hospital 5 4 1 1 2 1   
Private GP 6 6 1  1    
Drug retailers 15 9 4 0 4 2 6 0 
Pharmacy 13 8 3 0 4 2 4  
Drug shop 4 3 1 0 1 1 2  
Households 19 0 0 0 1 0 19 6 
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Figure 1: Data collection methods by type of data collection point category (Human Health) 
We categorised livestock health papers according to data collections points, included antibiotic 
suppliers and those who administer them, resulting in five categories: livestock keepers, drug retailers, 
pharmaceutical representatives (suppliers of drugs direct to livestock keepers in some settings e.g. 
Bangladesh aquaculture), veterinarians and feed retailers (Table 2b).  Papers often did not give specific 
details of type of livestock keepers including scale of their enterprise e.g. commercial farmers or small 
holders or households with livestock or pastoralists and similarly with fish farmers. In addition, drug 
retailers were often not described or broken down into categories of registered or informal, veterinary 
drug stores or agri-stores etc.  As with human health studies, several papers covered more than one 
data collection point. All of the 30 papers reviewed included livestock keepers, and 13 used an 
additional source of data, which included six papers using drug retailers, four using pharmaceutical 
reps, two using veterinarians and one using a feed retailer.  
The methods used in these livestock health studies were fewer than those in the human studies, with 
only three types (Table 2b): 
1. Questionnaire: structured and semi-structured usually conducted face-to-face with livestock 
keepers, drug retailers, veterinarians etc. 
2. Treatment log: the treatment records kept by livestock keepers for individual animals or 
groups (flocks, herds or ponds) 
3. Used packaging bins: the packaging of all antibiotics used during a specified time period are 
collected in bins and analysed. This method can be used on its own or to validate 
questionnaires recalling usage over the same period. 
4. A combination of the above: typically this was a questionnaire together with treatment log 
or used packaging bins 
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A questionnaire was the most common method, used in almost all of the studies (28/30) that included 
livestock keepers as a source and these often included recall questions on medications used in the 
production cycle, the past month or up to 6 months prior. Data from livestock keepers was also 
captured using treatment logs in three papers. In one of these, treatment logs were available as the 
farm was a national research farm (Manimaran et al., 2014) whilst in another, logs were being kept 
prospectively as part of the research project (Roderick et al., 2000). Similarly, in the third paper, 
records were being kept prospectively as part of farmers’ participation in a project on antimicrobial 
usage, which included an intervention of free advice on husbandry and disease diagnostics and 
management as an incentive (Carrique-Mas and Rushton, 2017). This same project also asked farmers 
to keep all packaging of medications, which were later used to validate records. The researchers 
commented that previous attempts to collect data on antimicrobial usage on farms through 
unannounced visits had been full of challenges; famers recall was poor due to lack of record keeping 
and there was an element of mistrust. A second paper, which used packaging bins, compared contents 
with recall over a one month and a six-month period (Redding et al., 2014)5. Data collection from all 
other types involved the use of face-to-face questionnaires only. 
Table 2b: Data collection methods used by type of data collection point in livestock health sector 
Livestock Papers n=30 Methods 
Data collection 
points 
No. of 
papers 
Questionnaire Treatment 
Log 
Used packaging 
bin 
All data 
collection 
points 
30 28 3 2 
Livestock 
keepers  
30 28 3 2 
Drug retailers 6 6   
Pharmaceutical 
reps 
4 4   
Veterinarians 2 2   
Feed retailers 1 1   
 
2. Sampling strategies 
Table 3a presents the sampling strategies used by the human health papers, highlighting the type of 
sampling frame used from which to select the sample, and sample sizes. Figure 2 presents the analysis 
of sampling frame sources only, over the three main categories of data collection points. Of the 21 
papers analysed within the health care facilities group, 17 relied on existing lists of health facilities 
and/ or patient lists within these facilities as a sampling frame, while four papers did not state their 
source. None of the papers in this group conducted their own census. Sample sizes in papers on health 
care facilities were mostly small (up to 100 facilities) with only two papers including >100 facilities. 
The highest (Guyon et al., 1994), included 635 facilities (177 health centres and 461 sub-centres) in 
Bangladesh. Sample sizes at the patient level within the health care facility group were mostly less 
than 1,000 patients, with three papers between 1,001 and 10,000, three between 10,001-100,000 and 
                                                          
5 Method comparison gave mixed results: “Agreement between the bins and self-report was relatively poor for 
both the quantity and types of antibiotics used. The bins appeared to perform better than self-report when 
bottles and mls of antibiotics were measured, while self-report appeared to perform better for intra-mammary 
infusions. The bins also appeared to perform better when data pertaining to an extended time period (six 
months) were collected.” (Redding et al., 2014) 
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two studies over 100,000. These two papers with the largest sample sizes involved longitudinal studies 
for a year or more. They may be hospital based and would include inpatient as well as outpatients 
records (Alvarez-Uria et al., 2014). Alternatively, they may cover a range of provider types with exit 
interviews e.g. 10 hospitals, 10 private clinics and 10 pharmacies with 30 “antibiotic encounters” (i.e. 
administered, prescribed or dispensed) in each, i.e. 900 each month for 24 months (Chandy et al., 
2013).  
Of the 15 papers using drug retailers, eight used existing lists of formal outlets for their sampling 
frame, either from lists of government registered / licenced outlets or pharmacy association lists. The 
remainder reported no sampling frame details. None of the papers in the drug retailer group 
conducted their own census. Sample sizes were mostly between 21-100 retailers, with patient 
numbers of up to 10,000 (e.g. 7,200 “antibiotic encounters” via exit interviews from 30 pharmacies 
over 24 months (Chandy et al., 2013) or similarly 30 pharmacies for 12 months (Kotwani et al., 2009) 
both from India).  
Eight of the 19 papers using households used existing lists (from government census, local health 
centre patient lists, or households already part of an existing study) for a sampling frame, whilst the 
remainder used none. None of these papers conducted their own census. Sample sizes were almost 
all over 100 households, with seven papers involving up to 1,000 individuals and four up to 10,000 
individuals which were regionally widespread (Jordan: 1943 families, 9282 individuals, Mexico: 1751 
families, Nigeria: 1080 households, Ethiopia: 1034 households).  
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Table 3a: Sampling frame sources and sample size of human health papers by type of data collection point 
Human health papers n=48 Sampling Frame Sample size 
facilities/households 
Sample size  
patients/ encounters/ prescriptions 
Data collection 
points 
No. of 
papers 
Existing 
list 
Conducted 
census 
Not 
stated 
<=20 21-
100 
>100 <=1,000 1,001-
10,000 
10,001-
100,000 
>100,000 
All data collection 
points 
48 29 0 18 3 8 13 16 8 4 2 
Hospitals and 
primary health 
care facilities  
21 17 0 4 3 3 2 5 3 3 2 
Public hospital 20 17  3 7 4  7 6 2 2 
Primary health 
care facility 
5 4  2 1  2 2 2   
Private hospital 5 5  1 2 2  1 2 1  
Private GP 6 3  3 2 1  3 2   
Drug retailers  15 8 0 7 2 4 2 4 1 3 0 
Pharmacy 13 7  5 5 3 2 5 3 3  
Drug shop 4 3  1 2 1 2 2    
Households 19 8 0 11 0 1 9 7 4 0 0 
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Figure 2: Sampling frame sources by data collection point category (Human Health)  
The sampling strategies of the livestock sector papers are presented in Table 3b. Twenty-one of the 
30 papers involving livestock keepers did not report using a sampling frame, whilst nine used an 
existing list of farms or livestock keepers (from government offices e.g. Department of Agriculture or 
District Livestock Production office, or from existing studies). Only one of these papers also accessed 
data from vets and drug retailers, again using an existing list from the District Livestock Production 
office. The remainder of the papers in the other categories did not report using any sampling frame. 
None of the livestock sector papers conducted their own census to form a sampling frame. Sample 
sizes were mostly between 11-500 livestock keepers, with only two over 500. Both of the latter were 
in Bangladesh, one with 1890 fish farmers (Ali et al., 2016), the other with 521 livestock keeping 
households (Roess et al., 2015). Most studies involving drug retailers and pharmaceutical reps had a 
sample size of 10 or less, as did both of the veterinarian studies and the feed retailer study. Sample 
sizes based on number of animals treated were not stated apart from in two studies, one of which 
was a single dairy farm in India with 119 cases of mastitis (Manimaran et al., 2014) and the other 
involved a total of approximately 220,000 chickens spread over 92 farms in the Cameroon (Kamini et 
al., 2016). 
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Table 3b: Sampling frame sources and sample size of livestock health papers by type of data 
collection point 
Livestock papers n=30 Sampling frame Sample size* facilities/ 
veterinarians/ farms & livestock 
keepers 
Data Collection points No. of 
papers 
Existing 
List 
Conduct 
census 
Not 
stated 
<=10 11-500 >500 
All data collection 
points 
30 9 0 21 4 24 2 
Livestock keepers  30 9  21 6 25 2 
Drug retailers 6 1  5 4 1  
Pharmaceutical reps 4   4 2 1  
Veterinarians 2 1  1 2   
Feed retailers 1   1 1   
* Does not include patient numbers (only two studies included number of animals as flock/herd sizes) 
 
3. Metrics and outcomes 
The antibiotic use metrics/ outcomes from the human health papers across the full spectrum of data 
collection points are presented in Table 4a, whilst Figure 3 shows them across the three main 
categories.  Antibiotic use can be described as the exposure of a given individual or population over a 
given time period to a technical unit of antibiotic, i.e. quantification of antibiotics e.g. number of mg 
or packages (Collineau et al., 2017). For human use, the Defined Daily Dose (DDD) is commonly 
proposed and recommended by WHO as the assumed measure of use, calculated as the assumed 
average maintenance dose for a drug for a 70 kg adult for its main indication. Only 12 papers included 
a DDD associated metric and they were all in papers using providers, not households, as data collection 
points. Of the 21 papers collecting data from health care facilities, nine used a DDD associated metric 
whilst only five of the 15 papers from drug retailers did the same. The vast majority of papers collecting 
data from health care facilities produced metrics based on the WHO INRUD methods i.e. % of patients 
prescribed, dispensed or using antimicrobials or antibiotics, and % of antibiotics prescribed, dispensed 
or used by antibiotic type. In 15 papers collecting data from drug retailers, again INRUD metrics 
predominated but with a wider range of indicators i.e. % of patients prescribed, dispensed or using 
antimicrobials or antibiotics, % of antibiotics prescribed, % of antibiotics dispensed with or without a 
prescription, % dispensed or used by antibiotic type, and % of antibiotics prescribed, dispensed or used 
by symptom or diagnosis. Household studies reported a similar range of metrics to the drug retailer 
papers, with all 19 of them collecting data on % of patients using antimicrobials or antibiotics.  
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Table 4a: Main antibiotic use metrics or outcomes for human health papers by type of data collection point 
Human health papers n=48 
 
Main Metrics/ Outcomes 
Data collection points No. of papers DDD 
associated 
metric 
% patients P/D/U 
AMs or ABs  
% of antibiotics 
P/D/U by AB 
type 
% of AMs or 
ABs dispensed 
with or without 
Rx 
% of antibiotic 
P/D/U by 
symptom or 
diagnosis 
Course 
duration 
Inappropriate 
use or non-
compliant 
dispensing 
All data collection 
points 
48 12 39 20 18 19 9 8 
Hospitals and primary 
health care facilities 
21 9 18 9 0 3 4 3 
Public hospital 20 9 16 12  4 4 4 
Primary Health care 
facilities 
5 4 5 4  1   
Private Hospital 5 3 5 3     
Private GP 6 4 6 3  1   
Drug Retailers  15 5 10 4 8 5 1 1 
Pharmacy 13 5 9 3 8 5  1 
Drug Shop 4  4 3 2 3 1  
Households 19 0 19 11 12 11 5 1 
Table Key: AMs = Antimicrobials, ABs = Antibiotics, P = Prescribed, D = Dispensed, U = Used, Rx = Prescription 
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Figure 3: Main metric or outcome by type of data collection point category (Human Health)   
[Key: AMs = Antimicrobials, ABs = Antibiotics, P = Prescribed, D = Dispensed, U = Used, Rx = Prescription] 
Antibiotic use metrics/ outcomes used in livestock sector papers are presented across the range of 
data collection points in Table 4b, and shown specifically for livestock keepers in Figure 4. Several 
metrics exist in the livestock sector which attempt to match the human DDD metric such as DDDvet, 
mg used per kg of meat produced or per population correction unit (PCU) and Defined Course Dose 
(DCDvet) (Collineau et al., 2017).  Only four of the 30 papers involving livestock keepers presented 
DDD associated metrics. The most common outcomes from the papers collecting data from livestock 
keepers were reasons for using antibiotics (21/30 papers), followed by % of respondents using 
antibiotics (20) and most common antibiotic used by type (17). The “Reason for use” outcome included 
data based on symptoms or conditions and whether antibiotics were used for diseased animals 
(therapeutic), to prevent spread of disease within an exposed population (prophylactic) or within an 
unexposed but at risk group (metaphylactic). Livestock keepers were also asked whether they used 
the antibiotics appropriately (primarily observation of withdrawal periods) and the dose, course 
duration and administration route. The only paper identified covering both human and livestock 
antibiotic use Roess et al. (2013), involved asking individuals within a human health study whether 
they kept any livestock. If so, they were asked to recall if any “treatments” (which included antibiotics, 
anti-parasitics or herbal) had been given in the past six months and their reasons for use. The studies 
using retailers, pharmaceutical reps, vets and feed retailers focussed almost exclusively on the most 
common antibiotics prescribed, dispensed or used or on the reasons for use (as above). 
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Table 4b: Main antibiotic use metrics or outcomes for livestock health papers by type of data collection point 
Livestock papers n=30 Main Metrics/ Outcomes 
Data collection 
points 
No. of 
papers 
DDD 
associated 
or similar 
metric 
% 
respondentsP/D/U 
AMs or ABs  
Most 
common 
antibiotics 
P/D/U by 
type 
% of AMs or 
ABs 
dispensed 
with or 
without Rx 
Reasons 
for use by 
symptom, 
diagnosis 
or 
Th/Pr/Me 
Route  Dose Course 
duration 
Inappropriate 
use / 
observation 
of 
withdrawal 
time  
All data 
collection 
points 
30 4 20 21 1 21 6 5 5 7 
Livestock 
Keepers  
30 4 20 17 1 21 6 5 5 7 
Drug Retailers 6   5  4 1 1 1  
Pharmaceutical 
reps 
4   3  4 1 1 1  
Veterinarians 2   2  2     
Feed retailers 1   1  1     
Table Key: DDD = Defined Daily Dose, AMs = Antimicrobials, ABs = Antibiotics, P = Prescribed, D = Dispensed, U = Used, Rx = Prescription, Th = 
Therapeutic, Pr = Prophylactic, Me = Metaphylactic 
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Figure 4: Main metric or outcome from livestock keepers as data collection point 
[Key: DDD = Defined Daily Dose, AMs = Antimicrobials, ABs = Antibiotics, P = Prescribed, D = Dispensed, U = Used, Rx = 
Prescription, Th = Therapeutic, Pr = Prophylactic, Me = Metaphylactic] 
4. Geographical location and scope 
Table 5a shows the location, including the global region (also Figure 5), urban or rural location, and 
geographical scope of the human health papers. Four of the 48 papers were located in multiple 
countries and from more than one region: eight countries were included from across South Asia, Sub-
Saharan Africa and Latin America by Rogawski et al. (2017), six countries from Sub-Saharan Africa and 
South Asia by Hopkins et al. (2017), three countries from the Middle East and North Africa and Central 
Asia by Belkina et al. (2014) and both India and South Africa by Holloway et al. (2011). 
Fifteen of the 21 papers involving health care facilities took place in South Asia and six in sub-Saharan 
Africa, with public hospitals being the main source of data. Similarly, papers including drug retailers 
were also in sub-Saharan Africa (10/15) and S Asia (7/15) with pharmacies being the main data 
collection points. Household survey studies were more evenly spread across S Asia, sub-Saharan 
Africa, the Middle East and North Africa, and East Asia and Pacific. The urban setting predominated in 
the papers using data collection points from all three categories, with roughly twice as many of the 
reviewed papers being in urban as opposed to rural areas.  Only a few studies had nationwide 
representation, all of which used public hospitals or private hospitals as a data collection point. Of the 
remainder, the majority of papers using health care facilities covered several major administrative 
areas, whilst drug retailer papers were mostly from smaller areas, either i) a single city (Cairo: Sabry 
et al. (2014)), ii) a group of wards within a city (New Delhi: Kotwani and Holloway (2011)), or a single 
district (Vellore, India: Chandy et al. (2013)). Similar results were found in papers using household data 
collection. 
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Table 5a: Geographical location and scope of human health papers 
Human health 
papers 
n=48 
Geographical location by World Bank region Urban (U)  
or Rural (R) 
Geographical scope 
Data 
collection 
points 
No. of 
papers 
East 
Asia 
& 
Pacific 
Europe 
& 
Central 
Asia 
Latin 
America 
& the 
Caribbean 
Middle 
East & 
North 
Africa 
South 
Asia 
Sub-Saharan 
Africa 
U R Not 
stated 
Nationwide Several major 
administrative 
areas  
Small selected 
area, single city 
or district 
All data 
collection 
points 
48 9 2 3 7 23 17 30 13 15 3 15 33 
Hospitals 
and 
primary 
health care 
facilities 
21 3 0 0 0 15 6 12 7 7 3 7 14 
Public 
hospital 
20 3    12 10 11 5 8 3 8 9 
Primary 
Health care 
facilities 
5     5  10 2   3 2 
Private 
Hospital 
5     4 2 4 5 1 1 4 1 
Private GP 6     7  6 4   5 2 
Drug 
Retailers 
15 1 0 1 1 7 10 13 5 2 0 5 12 
Pharmacy 13 1   1 7 10 12 5 1  5 8 
Drug Shop 4   1  1 7 4 3 1  2 4 
Households 19 5 2 2 6 6 7 9 4 7 0 8 11 
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Figure 5: Location by World Bank region by data collection point category 
Table 5b presents the geographical location (also Figure 6) and scope of livestock sector papers. Sub-
Saharan Africa and East Asia and the Pacific were the predominant areas covered followed by S Asia 
and one study from Latin America. No papers in the review were from the regions of the Middle East 
and North Africa or Europe and Central Asia. Most studies did not specify if they were rural or urban, 
but of the 10 that did, most were urban or likely peri-urban and covered a range of animals including 
poultry, pigs, dairy cows and fish. No studies had nationwide coverage, only a handful (5/30) covered 
several administrative areas, with the rest focusing on a small selected area (often selected 
purposively for its density of livestock). 
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Table 5b: Geographical location and scope of livestock papers 
Livestock papers 
n=30 
Geographical location by World Bank region Urban (U) 
or Rural (R) 
Geographical scope 
Data collection 
points 
No. of 
papers 
East Asia 
& Pacific 
Latin America 
& the 
Caribbean 
South Asia Sub-
Saharan 
Africa 
U R Not 
Specified 
Nationwide Several major 
administrative 
areas  
Small selected 
area, single city or 
district1 
All data collection 
points 
30 10 1 8 11 6 4 20 0 5 25 
Livestock Keepers  30 10 1 8 11 6 4 20  5 25 
Drug Retailers 6   3 3 1 1 4   6 
Pharmaceutical 
reps 
4   4    4   4 
Veterinarians 2 1   1 1  1   2 
Feed retailers 1 1    1     1 
1Some of these were purposively selected for density of livestock keeping establishments 
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Figure 6: Location by World Bank regions by data collection point (Livestock Health) 
5. Symptoms or diagnosis in human health papers6 
Table 6 shows the scope of the human health papers with respect to symptoms or diagnoses covered. 
Overall, most studies, including those with households, did not have a specific disease focus and 
covered antibiotic use for all or any conditions. Of those with a symptom/disease focus, most covered 
more than one or used broad symptoms such as diarrhoea, respiratory symptoms or acute fever. 
Three studies related to antibiotic use for suspected or confirmed cases of malaria from a variety of 
health care facilities or drug retailer outlets.  
  
                                                          
6 Livestock studies did not focus on specific diseases apart from one study on mastitis in dairy cows  
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Table 6: Scope of human health papers by symptom or diagnosis 
Human health papers  
n= 48 
Symptom or Diagnosis 
Data collection 
point 
No. of 
papers 
Acute 
respiratory 
infection 
Acute 
fever 
Diarrhoea Malaria Orthopaedic Pneumonia Any 
condition 
All data 
collection points 
48 9 4 8 3 1 2 32 
Hospitals and 
primary health 
care facilities 
21 3 3 4 3 1 1 11 
Public hospital 20 3 3 3 3 1  12 
Primary Health 
care facilities 
5 2 1 3   1 1 
Private Hospital 5 1 1 2 1   3 
Private GP 6 2 1 3    3 
Drug Retailers  15 1 2 4 1 0 0 13 
Pharmacy 13  1  1   11 
Drug Shop 4 1 1 1 1  1 2 
Households 19 5 2 4 0 0 0 13 
 
6. Species included in livestock papers 
The livestock papers reviewed did not have a specific disease focus apart from one study, which 
related to mastitis in dairy cows. As an alternative, Table 7 presents the analysis of livestock papers 
based on the species included. The majority of papers (24/30) focussed on a single species, the most 
common being poultry followed by aquatic species, cattle and pigs and in a couple of studies, sheep 
and goats. All studies using pharmaceutical reps involved aquaculture. The single study involving feed 
retailers involved pigs and poultry (Om and McLaws, 2016). 
Table 7: Scope of Livestock studies by species 
Livestock papers n=30  Species included 
Data collection point No. of 
papers 
Aquatic Bovine Porcine Poultry Sheep & 
Goats 
All data collection 
points 
30 11 7 6 14 2 
Livestock Keepers  30 11 7 6 14 2 
Drug Retailers 6 3 1  2  
Pharmaceutical reps 4 4     
Veterinarians 2   1 2  
Feed retailers 1   1 1  
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Current developments 
Based on our key informant interviews we have included a couple of key current developments in this 
area of granular data collection in LMICs, in terms of both standard methodologies and research 
projects. 
Standard methodologies 
In the near future, the WHO is due to publish an updated methodology on measuring antibiotic use in 
hospitals using point prevalence surveys (PPS) (WHO, 2017b). The methodology is adapted for use in 
LMICs from the European Centre for Disease Prevention and Control protocol for PPS of Healthcare 
Associated Infections and Antimicrobial Use in European Acute Care Hospitals (ECDC, 2016) and from 
the Global PPS, Antwerp, Belgium. The methodology aims to provide a standard to collect data on 
prescribing of antibiotics for inpatients by substance name, indication and by facility. Details of 
sampling are provided. At a hospital level, either all hospitals should be included or a representative 
sample is made using the ECDC’s systematic sampling design. The latter includes using a list of 
hospitals, which are ranked based on bed numbers. The number of hospitals is calculated from 
estimated prevalence of antibiotic use and desired confidence level. A sampling interval is then 
calculated for systematic sampling of the hospitals. At a patient level, all inpatients are to be included 
in hospitals with <700 beds. For larger hospitals, every second or third patient is included. 
Epidemiological and risk factor data are also to be collected for all inpatients, with or without antibiotic 
use. Data collection on antibiotic treatments must be based on international non-proprietary names 
and include the single dose unit and the daily frequency to enable calculation of the prescribed daily 
dose. Information on indication and diagnosis are also to be collected.  In addition, outward antibiotic 
stock movements and availability are to be recorded at the hospital level and patient level. Similarly, 
the WHO has plans for developing a methodology for surveying use at the community level in LMICs 
at the level of the prescriber, dispenser and individual, though work on this is currently in the very 
early stages.  
Research projects 
A current research project is investigating community level Antibiotic Access and Use (ABACUS) in 
LMICs (Wertheim et al., 2017), within the INDEPTH-Network Health and Demographic Surveillance 
System (HDSS) sites. It is a multicentre study using interviews among drug suppliers and community 
members across Bangladesh, Mozambique, Vietnam, Ghana, Thailand and South Africa over a 2.5-
year period and will be completed by the end of 2018. Antibiotic suppliers are mapped using official 
local authority lists and local community knowledge through household surveys so as to include 
informal suppliers such as street vendors. As per the INRUD/WHO methodology, twenty suppliers will 
be selected for customer exit interviews based on exploratory studies of number of antibiotic 
encounters per day. At each, up to 30 antibiotic encounters will be observed for a single day for four 
separate days, spread over a year to account for seasonal variations. This will total 2,400 antibiotic 
encounters at each study site. Outcomes will focus on i) antibiotic exposure: the proportion of 
customers leaving a supplier with antibiotics and ii) the antibiotic burden: the DDD supplied per 100 
customer encounters for each type of antibiotic. To enable the latter to be calculated, the antibiotic 
name, strength, units and dose will be recorded at the exit interview. A copy of the exit interview 
questionnaire is available as open access and is included as Annex 4.  
In addition, Meenakshi Gautham and colleagues are conducting an exploratory study of antibiotic use 
by informal providers without medical qualifications in rural West Bengal India, using a mix of 
quantitative and qualitative methods (Gautham et al., 2014).  
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Summary and reflections on the literature 
This review has identified and collated current standard procedures and protocols, and the range of 
methods used by research projects, as well as identifying some recent developments in antibiotic 
usage data collection at the granular level in LMICs. The review indicated that considerable experience 
and expertise exists on antibiotic use data collection, and a number of valuable resources are 
available. Several standard tools for assessing medicine use at the granular level exist in human health 
for a variety of data collection points, mainly linked to WHO and/or INRUD, and focused on measuring 
rational drug use (rather than volumes per se). However, none were found in livestock health at the 
granular level, and therefore none from a One Health perspective. Numerous research papers have 
been published in this area, particularly in human health and to a somewhat lesser extent for livestock 
(only one attempting to cover both). A wide range of methods have been used to study antibiotic use 
in human health and a more limited range in livestock health. Within human health, the most common 
are patient exit interviews, record extraction and household questionnaires, with questionnaires also 
very common in the livestock field, though other approaches include observation, bulk purchase /sales 
records and inventories for human health, and treatment logs and used-packaging bins for livestock. 
The vast majority of human health papers produced outputs relating to INRUD methods, e.g. % of 
patients prescribed or receiving antibiotics, with most livestock papers using similar metrics e.g. % of 
livestock keepers using antibiotics. Only a minority of human health and livestock papers produced 
Defined Daily Dose (DDD)7 related metrics. Only one study (livestock) was identified which compared 
different data collection methods for measuring antibiotic volumes.  
A number of additional gaps are notable in the existing tools and literature as a basis for studying 
antibiotic volumes and use. Firstly, geographical coverage of existing studies is very patchy both across 
and within countries, with only a few hospital studies having nationwide representation, and rural 
areas generally less likely to be studied. Most human health and livestock papers had relatively small 
sample sizes, and apart from studies on registered health facilities and pharmacies, it was often 
unclear whether the sample was drawn from a complete sampling frame. Most standard protocols 
and papers for human health focused on registered health care facilities and drug outlets, with 
relatively few including informal providers, and none including itinerant drug sellers and market stalls. 
Coverage of livestock keeper types was also patchy, with many papers giving insufficient information 
about livestock keeper type. Livestock papers were typically species specific, with poultry and aquatic 
species predominating, and no studies including all livestock. Finally, no resources or papers which we 
identified adopted a total market approach i.e. none included all providers of antibiotics within a given 
geographical area, though this is the aim of ABACUS. Using a total market approach is demanding in 
terms of logistics and creation of comparable tools across providers, but would be very valuable to 
assess the relatively market shares of different provider types.  
Next steps 
A roundtable workshop and discussion will be held in London on 21 and 22 November 2017. On Day 
One we will hear updates from the WHO, OIE and Fleming Fund on current plans for capturing 
antibiotic use data and the results of this review will be presented along with presentations from a 
number of researchers from both human and livestock health sectors, focusing on their methods and 
their experiences and challenges from the field. Day Two will consist of open discussions on the 
methodological issues and challenges from Day One’s presentations and from fellow participants and 
a final session to discuss how to move forward.  
                                                          
7 DDD is the assumed average maintenance dose for a drug for a 70 kg adult for its main indication 
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Name Institution 
Angkana Sommanustweechai LSHTM 
Arno Muller WHO 
Barbara Häsler RVC 
Barbara Wieland CGIAR 
Christie Peacock  SIDAI 
Cristina Lussiana  PSI 
Dishon Muloi  Edinburgh University 
Elisabeth Erlacher-Vindel OIE 
Eric Fevre Liverpool University 
Franck Berthe World Bank 
Jonathan Rushton Liverpool University 
Kathy Holloway IDS/WHO 
Liz Tayler WHO 
Lucy Coyne Liverpool University 
Marco Haenssgen Oxford University 
Megan Littrell  PATH 
Nigel French Massey University 
Paul Coleman H2O Venture Partners 
Rezin Odede  SIDAI 
Stephen Poyer PSI 
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Annex 2: Human health papers reviewed 
 
Author Title Country 
1 Al-Azzam et al. (2007) Self-medication with Antibiotics in Jordanian population Jordan 
2 Ali et al. (2013) Trends of empiric antibiotic usage in a secondary care hospital, 
Karachi, Pakistan 
Pakistan 
3 Alvarez-Uria et al. 
(2014) 
High prescription of antimicrobials in a rural district hospital in 
India 
India 
4 Awad et al. (2005) Self-medication with Antibiotics and Antimalarials in the 
community of Khartoum State, Sudan 
Sudan 
5 Barah et al. (2009) Irrational use and poor public beliefs regarding antibiotics in 
developing countries: a pessimistic example of Syria 
Syria 
6 Basak and 
Sathyanarayana (2010) 
Evaluating medicines dispensing patterns at private 
community pharmacies in Tamilnadu, India 
India 
7 Belkina et al. (2014) Antibiotic use and knowledge in the community of Yemen, 
Saudi Arabia, and Uzbekistan 
Yemen, Saudi Araba, 
Uzbekistan 
8 Bharathiraja et al. 
(2005) 
Factors affecting antibiotic prescribing pattern in paediatric 
practice 
India 
9 Calva (1996) Antibiotic use in a Periurban community in Mexico: a 
household and drugstore survey 
Mexico 
10 Chandy et al. (2013)   Patterns of antibiotic use in the community and challenges of 
antibiotic surveillance in a lower-middle-income country 
setting: a repeated cross-sectional study in Vellore, south India 
India 
11 Nga et al. (2014)  Antibiotic sales in rural and urban pharmacies in Northern 
Vietnam: an observational study 
Vietnam 
12 Esimone et al. (2007) Utilization of antimicrobial agents with and without 
prescription by out-patients in selected pharmacies in South-
eastern Nigeria 
Nigeria 
13 Federal Ministry of 
Health (2010) 
Access to and rational use of medicines at household level Nigeria 
14 GARP (2010) First report on antibiotic use and resistance in Vietnam 
hospitals in 2008-2009 
Vietnam 
15 Gebrekirstos et al. 
(2017) 
Non-prescribed antimicrobial use and associated factors 
among customers in drug retail outlet in Central Zone of 
Tigray, northern Ethiopia: a cross-sectional study 
Ethiopia 
16 Guyon et al. (1994) A baseline survey on use of drugs at the primary health care 
level in Bangladesh 
Bangladesh 
17 Hadi et al. (2008) Optimizing antibiotic usage in adults admitted for fever by a 
multifaceted intervention in an Indonesian governmental 
hospital 
Indonesia 
18 Holloway et al. (2011) Surveillance of community Antimicrobial Use in resource-
constrained settings: experience from five pilot projects 
India 
19 Hopkins et al. (2017) Impact of introduction of rapid diagnostic tests for malaria on 
antibiotic prescribing: analysis of observational and 
randomised studies in public and private healthcare settings 
Afghanistan, Cameroon, 
Ghana, Nigeria, 
Tanzania, and Uganda 
20 Jassim (2010) In-home Drug Storage and Self-medication with Antimicrobial 
Drugs in Basrah, Iraq 
Iraq 
21 Kagashe et al. (2011) An assessment of dispensing practices in private pharmacies in 
Dar-es-Salaam, Tanzania 
Tanzania 
22 Kibuule et al. (2016) Antibiotic use in acute respiratory infections in under-fives in 
Uganda: findings and implications 
Uganda 
23 Kotwani et al. (2009) Methodology for surveillance of antimicrobials use among out-
patients in Delhi 
India 
24 Kotwani and Holloway 
(2011) 
Trends in antibiotic use among outpatients in New Delhi, India India 
25 Kotwani et al. (2012) Antibiotic-Prescribing Practices of Primary Care Prescribers for 
Acute Diarrhea in New Delhi, India 
India 
26 Kotwani and Holloway 
(2014) 
Antibiotic prescribing practice for acute, uncomplicated 
respiratory tract infections in primary care settings in New 
Delhi, India 
India 
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27 Kumari et al. (2008) Antimicrobial prescription patterns for common acute 
infections in some rural & urban health facilities of India 
India 
28 Larsson et al. (2000) Antibiotic medication and bacterial resistance to antibiotics: a 
survey of children in a Vietnamese community 
Vietnam 
29 Maharana et al. (2017) Storage, reuse, and disposal of unused medications: A cross-
sectional study among rural households of Singur, West 
Bengal 
India 
30 Mbonye et al. (2016) Prescription for antibiotics at drug shops and strategies to 
improve quality of care and patient safety: a cross-sectional 
survey in the private sector in Uganda 
Uganda 
31 Means et al. (2014) Correlates of Inappropriate Prescribing of Antibiotics to 
Patients with Malaria in Uganda 
Uganda 
32 Mukonzo et al. (2013) Over-the-counter suboptimal dispensing of antibiotics in 
Uganda 
Uganda 
33 Ndhlovu et al. (2015) Antibiotic prescribing practices for patients with fever in the 
transition from presumptive treatment of malaria to ‘confirm 
and treat’ in Zambia: a cross-sectional study 
Zambia 
34 Nguyen et al. (2011) Unnecessary antibiotic use for mild acute respiratory 
infections during 28-day follow-up of 823 children under five 
in rural Vietnam 
Vietnam 
35 Nwolisa et al. (2006) Prescribing Practices of Doctors Attending to Under Fives in a 
Children’s Outpatient Clinic in Owerri, Nigeria 
Nigeria 
36 Ocan et al. (2014) Factors predicting home storage of medicines in Northern 
Uganda 
Uganda 
37 Okumura et al. (2002) Drug utilisation and self-medication in rural communities in 
Vietnam 
Vietnam 
38 Paudel et al. (2008) Prevalence of antimicrobial chemotherapy in hospitalized 
patients in the department of internal medicine in a tertiary 
care center 
Nepal 
39 Rogawski et al. (2017) Use of antibiotics in children younger than two years in eight 
countries: a prospective cohort study 
Bangladesh, Brazil, 
India, Nepal, Pakistan, 
Peru, South Africa, 
Tanzania 
40 Sabry et al. (2014) Antibiotic dispensing in Egyptian community pharmacies: An 
observational study 
Egypt 
41 Saradamma et al. 
(2000) 
Social factors influencing the acquisition of antibiotics without 
prescription in Kerala State, south India 
India 
42 Shankar et al. (2006) Prescribing Patterns among Paediatric Inpatients in a Teaching 
Hospital in Western Nepal 
Nepal 
43 Shankar et al. (2007) Prescribing Patterns in the Orthopaedics Outpatient 
Department in a Teaching Hospital in Pokhara, Western Nepal 
Nepal 
44 Stratchounski et al. 
(2003) 
The Inventory of antibiotics in Russian Home Medicine 
cabinets 
Russia 
45 Thu et al. (2012) Antibiotic Use in Vietnamese hospitals: A Multicenter Point-
Prevalence Study 
Vietnam 
46 Togoobaatar et al. 
(2010) 
Survey of non-prescribed use of antibiotics for children in an 
urban community in Mongolia 
Mongolia 
47 Wondimu et al. (2015) Household Storage of Medicines and Associated Factors in 
Tigray Region, Northern Ethiopia 
Ethiopia 
48 Yousif (2002) In-home drug storage and utilization habits: a Sudanese study Sudan 
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Annex 3: Livestock health papers reviewed 
 
Reference Title Country 
1 Alam and Rashid 
(2014) 
Use of Aqua-Medicines and Chemicals in Aquaculture in Shatkhira 
District, Bangladesh 
Bangladesh 
2 Ali et al. (2016) An assessment of chemical and biological product use in 
aquaculture in Bangladesh 
Bangladesh 
3 Bashahun and 
Odoch (2015) 
Assessment of antibiotic usage in intensive poultry farms in 
Wakisa District, Uganda 
Uganda 
4 Carrique-Mas et al. 
(2015) 
Antimicrobial Usage in Chicken Production in the Mekong Delta of 
Vietnam 
Vietnam 
5 Carrique-Mas and 
Rushton (2017) 
Integrated Interventions to Tackle Antimicrobial Usage in Animal 
Production Systems: The ViParc Project in Vietnam 
Vietnam 
6 Donkor et al. (2012) Epidemiological aspects of non-human antibiotic usage and 
resistance: implications for the control of antibiotic resistance in 
Ghana 
Ghana 
7 Geidam et al. (2012) Patterns of antibiotic sales by drug stores and usage in poultry 
farms: a questionnaire based survey in Maiduguri, Northeastern 
Nigeria 
Nigeria 
8 Nguyen Dang Giang 
et al. (2015) 
Occurrence and Dissipation of the Antibiotics Sulfamethoxazole, 
Sulfadiazine, Trimethoprim, and Enrofloxacin in the Mekong Delta, 
Vietnam 
Vietnam 
9 Holmström et al. 
(2003) 
Antibiotic use in shrimp farming and implications for 
environmental impacts and human health 
Thailand 
10 Irungu (2011) A pilot survey of farmers' antibiotic use in livestock in Kenya Kenya 
11 Islam et al. (2014) Obtainable drugs for fish hatchery operation and grow-out ponds 
in Bangladesh 
Bangladesh 
12 Kabir et al. (2004) Veterinary drug use in poultry farms and determination of 
antimicrobial drug residues in commercial eggs and slaughtered 
chicken in Kaduna State, Nigeria 
Nigeria 
13 Kamini et al. (2016) Antimicrobial usage in the chicken farming in Yaoundé, Cameroon: 
a cross-sectional study 
Cameroon 
14 Dang Pham Kim et 
al. (2013) 
First Survey on the Use of Antibiotics in Pig and Poultry Production 
in the Red River Delta Region of Vietnam 
Vietnam 
15 Kodimalar et al. 
(2014) 
A survey of chlortetracycline concentration in feed and its residue 
in chicken egg in commercial layer farms 
India 
16 Manimaran et al. 
(2014) 
Estimation of antimicrobial drug usage for treatment of clinical 
mastitis cases in organised dairy farm 
India 
17 Mukasa et al. (2012) Antibiotic misuse by farmers in Ngoma subcounty Nakaseke 
district, Uganda 
Uganda 
18 Nguyen et al. (2016) Use of Colistin and Other Critical Antimicrobials on Pig and Chicken 
Farms in Southern Vietnam and Its Association with Resistance in 
Commensal Escherichia coli Bacteria 
Vietnam 
19 Olatoye and Basiru 
(2013) 
Antibiotic usage and oxytetracycline residue in African Catfish 
(Clarias gariepinus) in Ibadan, Nigeria 
Nigeria 
20 Oluwasile et al. 
(2014) 
Antibiotic usage pattern in selected poultry farms in Ogun state Nigeria 
21 Om and McLaws 
(2016) 
Antibiotics: practice and opinions of Cambodian commercial 
farmers, animal feed retailers and veterinarians 
Cambodia 
22 Pham et al. (2015) Monitoring Antibiotic Use and Residue in Freshwater Aquaculture 
for Domestic Use in Vietnam 
Vietnam 
23 Redding et al. (2014) Comparison of two methods for collecting antibiotic use data on 
small dairy farms 
Peru 
24 Rico et al. (2013) Use of veterinary medicines, feed additives and probiotics in four 
major internationally traded aquaculture species farmed in Asia 
Vietnam 
25 Rico et al. (2014) Use, fate and ecological risks of antibiotics applied in tilapia cage 
farming in Thailand 
Thailand 
26 Roderick et al. 
(2000) 
The Use of Trypanocides and Antibiotics by Maasai Pastoralists Kenya 
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27 Roess et al. (2015) Household Animal and Human Medicine Use and Animal 
Husbandry Practices in Rural Bangladesh: Risk Factors for 
Emerging Zoonotic Disease and Antibiotic Resistance 
Bangladesh 
28 Sasanya et al. (2005) Use of sulphonamides in layers in Kampala district, Uganda and 
sulphonamide residues in commercial eggs 
Uganda 
29 Shamsuzzaman and 
Biswas (2012) 
Aqua chemicals in shrimp farm: A study from the south-west coast 
of Bangladesh 
Bangladesh 
30 Sharker et al. (2014) Drugs and chemicals used in Aquaculture activities for fish health 
management in the coastal region of Bangladesh 
Bangladesh 
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Annex 4: Example of Exit Interview Questionnaire (ABACUS study)  
Reproduced from open access publication (Wertheim et al., 2017) 
Supplementary File 8: eCRF_ antibiotic encounter customer exit questionnaire  
 
i. The following questions will be answered for each type of antibiotic supplied to a particular customer. 
ii. Tablets, capsules, paediatric formulations, as well as intravenous and intramuscular antibiotics are to be 
assessed, but not other formulae like droplets or creams. 
iii. The reason-for-encounter symptoms are based on the International Classification of Primary Care (ICPC-2e 
v5 May 2015). 
iv. As a matter of courtesy, the antibiotic supplier/dispenser should be informed that exit interviews will be 
conducted outside their facility.  
 
CUSTOMER EXIT INTERVIEW PARTICIPANT     
 …….…_........._......... 
[study site]_[antibiotic supplier]_[customer exit interview participant] 
Demographics  
1) Age       ………………………………years 
2) Sex          male / female 
3) Only if you are comfortable with it, I would like to ask for your permission to examine your antibiotic/s 
together with you. If you are not comfortable with this, I will respect this and complete the interview 
without inspection of your antibiotics.  
Permission provided?      yes / no 
Antibiotics 
4) What is the name of the antibiotic/s you receive (Generic name, not brand name)?   
            
       
 ………………………………………. 
5) What is the size of one tablet?    …………………mg / unknown 
6) How many tablets are supplied?   
 ………………………………………. 
7) For how many days is this antibiotic supplied?   ………………days / unknown 
8) Were these antibiotics prescribed by a health professional?   Yes / no 
9) For who is this antibiotic?       
(tick one; Myself/ Child family member / adult family member / friend or relative / animal / unspecified / 
other: …../ unknown) 
10) Are you comfortable with telling us about the illness for which you got this antibiotic? 
Yes / no 
If no, skip to Question 12 
11) If yes, for what illness did you receive this antibiotic?    Sore throat / cough / Flu / 
headache / Pain / Weakness / Wound / Dental / dyspnoea / ear / eye / nose / throat / fever / boil / 
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gastrointestinal / Sexually Transmitted Infection / gynaecological / male genital / urinary tract infection / 
Chest pain / musculoskeletal / preventive / skin and soft tissue / surgery-related / HIV related opportunist 
infections / other (specify) / unknown. 
12) Today is [select one option] the expiry date.    before / after / unknown 
13) Did you receive written instructions for use?    yes / no 
14) Did you receive verbal instructions for use?    yes / no 
15) How do you rate your overall experience with the medicine supplier attended?   
 Visual analogue scale 
We have finished the interview. Thank you for your participation. 
 
 
 
 
